CrunchBase is hiring! Check out our open positions →

Register | Login or Login

Home > Companies > Syndax Pharmaceuticals

Syndax Pharmaceuticals Picture

General Information
edit

Website	syndax.com
Category	BioTech
Phone	781.419.1400
Email	info@syndax.com
Employees
Founded	2005
Description	Cancer Therapeutics Developer

Offices
edit

Headquarters

460 Totten Pond Road
Suite 650
Waltham, MA, 02451
USA

People
edit

Arlene M. Morris

CEO

Joanna C. Horobin

President

Artthur M. Pappas

Member of Board

Funding
edit

TOTAL	$9M
FUNDING TOTAL	$9M
Series A, 3/10 Domain Associates MPM Capital Avalon Ventures Forward Ventures Pappas Ventures	$9M

Tags
edit

Syndax Pharmaceuticals
edit

Syndax Pharmaceuticals specializes is a clinical-stage pharmaceutical company focused on an HDAC inhibitor for solid tumors and hematological tumors

Recent Milestones
edit

Syndax Pharmaceuticals received $9M in Series A funding. (3/16/10)

Posted 3/15/10 at 11:10pm via onbiovc.com
Syndax Pharmaceuticals added Arlene M. Morris as CEO.

Posted 4/18/12 at 7:57pm
Syndax Pharmaceuticals added Joanna C. Horobin as President.

Posted 4/18/12 at 7:57pm

Videos

Screenshots
edit

Syndax Pharmaceuticals screenshot

Above: Home Page
Uploaded: 3/18/10

Sources

Syndax Pharmaceuticals, Inc.: Series A $9M (onbiovc.com) [edit]

Edit This Page
Last Edited 4/28/13

Revision History

Sharing

External Links

edit

CrunchBase API

JSON Representation of this page.
More API docs »

Sponsors

Become a Sponsor

Terms of Service | Privacy Policy | Licensing Policy